Postoperative radiotherapy for breast cancer: UK consensus ...

rcr.ac.uk

Postoperative radiotherapy for breast cancer: UK consensus statements

November 2016

Faculty of Clinical Oncology

rcr.ac.uk

Contents

UK consensus statements

3

Introduction

5

Why standards of care are needed ? the

patient/public perspective

5

Who this document is for

5

How this document was produced

5

1. Cardiac sparing

7

Background

7

Key points from consensus meeting:

8

Key references:

8

2. Breast boost radiotherapy after breast-

conserving surgery

9

Background and discussion

9

Key points from consensus meeting

11

Key references:

12

3. Safe omission of radiotherapy after breast-

conserving surgery

13

Background

13

Key points from consensus meeting

14

Key references

14

4. Internal mammary chain radiotherapy 15

Background

15

Key points from consensus meeting

16

Key references

16

5. Hypofractionation

17

Please note that updated consensus statements

on hypofractionation were published by the RCR

on 13 May 2021. The 2021 statements should be

read in conjunction with the statements in this

document.

Background

17

Key points from consensus meeting

17

Key references

18

6. Axillary management of sentinel lymph

node-positive disease

19

Background

19

Key points from consensus meeting

20

Key references

21

7. Partial breast radiotherapy after breast-

conserving surgery

22

Background

22

Key points from consensus meeting

23

Key references

23

Conclusion

24

Acknowledgements

25

Membership of core group

25

3

rcr.ac.uk

UK consensus statements

Cardiac sparing

Cardiac-sparing radiotherapy should be considered the standard of care for patients with left-sided breast cancer.

The heart should routinely be excluded from the radiotherapy field. All UK radiotherapy departments should have a breath-hold technique available. A target mean heart dose would help departments to implement breath-hold. In left-breast-affected patients undergoing radiotherapy not including the internal mammary chain (IMC),

>90% of patients should be treated to a mean heart dose of ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download